How and where to order Glucotrol and Glucotrol-XL (Glipizide) 5 mg, 10 mg tablets or capsules online on Advantage Home Telehealth, Inc. website:
|Prices:||from $0.29 per pill
|Discount:||10% coupon: DFHDCC
|Forms:||Glucotrol and Glucotrol-XL tablets 5 mg, 10 mg
|Type:||Glipizide brand, Glucotrol generic, Glucotrol-XL generic
|Payment:||Visa, Mastercard, AmEx, E-Check (ACH), Bitcoin
|Delivery:||Regular and express mail service
|Shipping:||Worldwide, including USA, UK, Europe, Canada, Australia
Glipizide (trade names include Glucotrol, Glibenese, Glibetic, Glucotrol XL, Glynase, Mindiab, Minidiab) is an oral rapid- and short-acting antidiabetic medication from sulfonylureas pharmacological group. This medicine is used for treating type 2 diabetes in patients who cannot control blood sugar levels only by diet and exercises. It works by causing the pancreas to release insulin, which helps to lower blood sugar and helps your body to use insulin better. Glipizide is used alone or in combined therapy with other antidiabetic drugs, a diabetic diet and exercises.
Glipizide, Metformin (Metaglip)
Glyburide, Metformin (Glucovance)
Metformin (Glucophage XR)
Metformin, Sitagliptin (Janumet)
Pharmacological and medical categories:
Medications for the treatment of diabetes type 2
Oral antidiabetic agents
A - Alimentary tract and metabolism
A10 - Drugs used in diabetes
A10B - Blood glucose lowering drugs, excl. insulins
A10BB - Sulfonylureas
A10BB07 - Glipizide
Non-insulin-dependent diabetes mellitus - E11
Indications and usage:
Glucotrol and Glucotrol XL (Glipizide) tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of use: not for treatment of type 1 diabetes or diabetic ketoacidosis.
Dosage and administration:
Recommended starting dose of glipizide is 5 mg once daily. Dose adjustment can be made based on the patient's glycemic control. Maximum recommended dose is 20 mg once daily.
Administer with breakfast or the first meal of the day.
For combination therapy with other blood-glucose-lowering agents, initiate the agent at the lowest recommended dose, and observe pati ents for hypoglycemia.
Dosage forms and strengt:
Glucotrol (Glipizide) tablets: 5 mg, 10 mg.
Glucotrol XL (Glipizide) extended release tablets: 2.5 mg, 5 mg, 10 mg.
Overdosage of sulfonylureas including Glipizide (Glucotrol and Glucotrol XL) can produce severe hypoglycemia. Mild hypoglycemic symptoms without loss of consciousness or neurologic findings should be treated with oral glucose. Severe hypoglycemic rea ctions with coma, seizure, or other neurological impairment are medical emergencies requiring immediate treatment. The patient should be trea ted with gluca gon or intra venous glucose. Patients should be closely monitored for a minimum of 24 to 48 hours since hypoglycemia may recur a fter a pparent clinical recovery. Clearance of glipizide from pla sma may be prolonged in persons with
liver disease. Because of the extensive protein binding of glipizide, dialysis is unlikely to be of benefit.
Known hypersensitivity to glipizide or any of the product's ingredients.
Hypersensitivity to sulfonamide derivatives.
Warnings and precautions:
Hypoglycemia: may be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.
Hemolytic anemia: can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non-sulfonylurea alternative.
Potential increased risk of cardiovascular mortality with sulfonylureas: inform patient of risks, benefits and treatment alternatives.
Macrovascular outcomes: no clinical studies have established conclusive evidence of macrovascular risk reduction with glipizide or any other anti-diabetic drug.
Adverse reactions, side effects:
Most common adverse reactions (incidence > 3%) of glipizide are dizziness, diarrhea, nervousness, tremor, hypoglycemia and flatulence.
To report suspected side effects of Glucotrol or Glucotrol XL (Glipizide) tablets contact Pfizer pharmaceutical company, or your local FDA.
Drug abuse and dependence:
Certain medications may affect glucose metabolism, requiring Glucotrol XL dose adjustment and close monitoring of blood glucose.
Miconazole: monitor patients closely. Severe hypoglycemia can occur when Glucotrol and oral miconazole are used concomitantly.
Fluconazole: monitor patients closely. An increase in Glucotrol AUC was seen after fluconazole administration.
Colesevelam: Glucotrol XL should be administered at least 4 hours prior to colesevelam.
Use in specific populations:
Geriatric, hepatically impaired patients: at risk for hypoglycemia with glipizide pills. Use caution in dose selection and titration, and monitor closely.
Patient counseling information:
Advise the patient to read the FDA-a pproved patient labeling.
Inform patients of the potential adverse reactions of Glucotrol and Glucotrol XL including hypoglycemia. Explain the risks of hypoglycemia, its symptoms and treatment, and conditions that predispose to its development to patients and responsible family members. Also inform patients about the importance of adhering to dietary instructions, of a regular exercise program, and of regular testing of glycemic control.
Inform patients that glipizide tablets should be swallowed whole. Inform patients that they should not chew, divide or crush tablets and they may occasionally notice in their stool something that looks like a tablet. In the Glucotrol XL tablet, the medication is contained within a non-dissolvable shell that has been specially designed to slowly release the drug so the body can absorb it.
Advise females of reproductive potential to inform their prescriber of a known or suspected pregnancy.
Advise breastfeeding women taking Glipizide (Glucotrol, Glucotrol XL) pills to monitor breastfed infants for signs of hypoglycemia (e.g., jitters, cyanosis, hypothermia, excessive sleepiness, poor feeding, seizures).
C - Australia
C - United States (Risk cannot be ruled out)
Salts and other forms:
Synonyms, international and chemical names:
Brands, generics, trade names:
Dipazide - Siam Pharmaceutical
Glez - Aristo Pharmaceuticals
Glibenese - Pfizer, Dexo Laboratoire
Glibetic - La Pharmaceuticals
Glidiab - Kai Yuen Pharmaceuticals
Glipizid - Domesco Medical Import-Export
Glipizide - Alphapharm, Drug Houses of Australia, IVAX, Merck, Mylan, Pliva, Sandoz, Teva
Gluco-Rite - Perrigo
Glucotrol - Pfizer
Glucotrol-XL - Pfizer
Glynase - USV
Luditec - Collins Productos Farmaceuticos
Melizide - Merck, Alphapharm, Serono, Summit, Zuellig Pharma
Mindiab - Pfizer
Minidiab - Pfizer
Minodiab - Pfizer, Kenfarma
Ozidia - Pfizer
Semi-Glynase - USV
APIs used in medicine in combinations with glipizide:
Here is a list of popular medications containing glipizide as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
|Trade name of the drug
||Pharmaceutical forms and doses
||Tablets; Oral; Glipizide 2.5 mgTablets; Oral; Glipizide 5 mgTablets; Oral; Glipizide 10 mg
||Tablets, Extended Release; Oral; Glipizide 2.5 mgTablets, Extended Release; Oral; Glipizide 5 mgTablets, Extended Release; Oral; Glipizide 10 mg
||PfizerDCH AurigaRoerigZuellig Pharma
||Tablets; Oral; Glipizide 1.5 mgTablets; Oral; Glipizide 2.5 mgTablets; Oral; Glipizide 5 mg
||Tablets; Oral; Glipizide 2.5 mgTablets; Oral; Glipizide 5 mg
||PfizerChemical Industries DevelopmentDexo LaboratoireDKSH DistributionFlex PharmaLaphal IndustriesPrimal ChemicalThe Glory MedicinaZentivaZuellig Pharma
Glipizide main article on Wikipedia: https://en.wikipedia.org/wiki/Glipizide
Glipizide compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/3478
Glipizide medicine on DrugBank: https://go.drugbank.com/drugs/DB01067
Glipizide FAQ on MedlinePlus (revised 10/15/2017): https://medlineplus.gov/druginfo/meds/a684060.html
Drug-induced low blood sugar on MedlinePlus (revised 10/11/2020): https://medlineplus.gov/ency/article/000310.htm
Glipizide tablets drug label info on DailyMed (revised January 23, 2015): https://dailymed.nlm.nih.gov/dailymed/lookup...
Glipizide ER film-coated extended-release tablets drug label info on DailyMed (revised November 22, 2019): https://dailymed.nlm.nih.gov/dailymed/lookup...
Glipizide XL extended-release tablets drug label info on DailyMed (revised May 24, 2021): https://dailymed.nlm.nih.gov/dailymed/lookup...
Glucotrol (Glipizide) tablets drug label info on DailyMed (revised June 7, 2021): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Glucotrol XL (Glipizide) extended-release tablets drug label info on DailyMed (revised August 17, 2018): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Glipizide containing drugs on Drugs-About.com: https://drugs-about.com/ing/glipizide.html
Glipizide for sale on Pharma Doctor: https://pharma-doctor.com/glipizide.html
Glucotrol (Glipizide) tablets 5 mg, 10 mg official prescribing information from the U.S. FDA (revised September 2008): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Glucotrol XL (Glipizide) 2.5 mg, 5 mg, 10 mg extended release tablets for oral use official prescribing and patient information from the U.S. FDA (revised 10/2015): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Glucotrol (Glipizide) tablets prescribing information from Pfizer pharmaceutical company (revised 10/2016): https://www.pfizer.com/products/product-detail/glucotrol
Glucotrol XL (Glipizide) tablets extended release prescribing and patient information from Pfizer pharmaceutical company (revised 05/2021): https://www.pfizermedicalinformation.com/en-us/glucotrol-xl
Minidiab (Glipizide) 5 mg tablets consumer medicine information from NPS MedicineWise (revised October 2019): https://www.nps.org.au/medicine-finder/minidiab-tablets
Minodiab (Glipizide) 5 mg tablets information leaflet from Medicines.org.uk (revised 08/2016): https://www.medicines.org.uk/emc/medicine/9851
Revised: July 2021
Home | About Us | Team | Solutions for Hospitals | Solutions for Home Health Agencies | Solutions for Self-Care | Solutions for Corporations | Contact
Copyright © 2008 - 2021 Advantage Home Telehealth, Inc. All Rights Reserved.